Unlocking the FDA: Processa Pharmaceuticals Joins Panel Discussion at World Orphan Drug Congress
Processa Pharmaceuticals to Participate in a Panel on Interaction with the FDA at the World Orphan Expo HANOVER, MD, May 22, 2023 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company now focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and safety for…